Therefore, more comprehensive clinical indicators such as insulin-like growth factor 1 (IGF-1) and estradiol should be investigated to better illustrate the relationship between endometrial polyps and insulin resistance, which is also a limitation of this study. This evidence concerns the gene IGF1 and endometrial polyp.